Health Care/Hospital
Biosion Announces Exclusive, Global License Agreement with Aclaris Therapeutics on two potential First-in-Class and Best-in-Class Immunology Assets
* Biosion receives over $40 million cash payment as upfront license fee and reimbursement for certain development costs & drug product materials, and 19.9% shares of common stock of Aclaris Therapeutics; additional regulatory and sales milestone payments exceed$900M with tiered single digit sal...
2024-11-18 21:50
1327
Akeso Biopharma to Attend Jefferies London Healthcare Conference and Morgan Stanley 23rd Asia Pacific Summit
HONG KONG, Nov. 18, 2024 /PRNewswire/ -- Akeso Biopharma (9926. HK) ("Akeso" or the "Company") is pleased to announce thatDr. Michelle Xia, the company's founder, chairwoman, president, and CEO, will attend Morgan Stanley's 23rd Asia Pacific Summit.Dr. Bing C. Wang, the company's chief financial ...
2024-11-18 21:16
1224
WELLlife COVID-19/Influenza A&B Home Test on Sale for Black Friday and Cyber Monday
BOLINGBROOK, Ill. , Nov. 18, 2024 /PRNewswire/ -- Stock up your family's medicine cabinet this Black Friday and Cyber Monday. WELLlife, a leading innovator in medical diagnostic and testing solutions, is increasing accessibility to respiratory illness testing in preparation for the year-end holi...
2024-11-18 21:00
1027
Bestqool Pro Advanced Series: Revolutionizing Red Light Therapy This Black Friday
NEW YORK, Nov. 18, 2024 /PRNewswire/ -- With winter just around the
corner, Bestqool is proud to offer a head start on wellness with their advanced
Pro Series
2024-11-18 21:00
1110
TenNor Announces Positive Topline Results from Rifasutenizol Phase III Trial for H. pylori Infection
SUZHOU, China, Nov 18, 2024 /PRNewswire/ -- TenNor Therapeutics, a clinical-stage company dedicated to developing novel therapies to address unmet needs in infectious diseases, announced today the successful completion of a phase III clinical trial of rifasutenizol (TNP-2198) for the treatment of...
2024-11-18 19:00
1189
FDA Grants Breakthrough Therapy Designation to Huahui Health's Libevitug (HH-003) for treatment of chronic Hepatitis D virus infection
BEIJING, Nov. 18, 2024 /PRNewswire/ -- Huahui Health, a clinical-stage biotechnology company focused on discovering and developing novel therapies in the areas of viral hepatitis, hepatology, and oncology, today announced that its investigational hepatitis D and B drug candidate, Libevitug (HH-00...
2024-11-18 18:40
1047
SoniVie Ltd., Appoints Veteran Medtech Executive Raymond W. Cohen as Chairman of its Board of Directors
TEL AVIV, Israel, Nov. 14, 2024 /PRNewswire/ -- SoniVie Ltd.
2024-11-18 08:00
1227
DermRays Black Friday Event Offers Year's Biggest Savings and Industry Recognition
PLEASANTON, Calif., Nov. 16, 2024 /PRNewswire/ -- This Black Friday, DermRays is excited to announce its most significant sale of the year, offering$130 off sitewide fromNovember 16-30th, 2024. With this limited-time discount, customers can experience the brand's advanced home laser hair removal ...
2024-11-16 21:00
1256
World-Class Scientists Gather at Tencent 2024 WE Summit in Chengdu to Share Cutting-Edge Discoveries
Five eminent speakers, including Nobel laureates and the top Chinese physicist Qi-Kun Xue, share groundbreaking insights at theTencent WE Summit in Chengdu. SHENZHEN, China, Nov. 15, 2024 /PRNewswire/ -- On November 3, the 12th Annual Tencent WE Summit took place at the Chengdu Science Fiction Mu...
2024-11-15 22:57
1788
Neurophet Appoints CTO Donghyeon Kim as Co-CEO, Joining Jake Junkil Been in Dual Leadership to Drive Global Growth
- Donghyeon Kim, Co-Founder and CTO of Neurophet, to Take On Dual Role as CEO, Heading Technology and Company Leadership - Aims to Strategically Expand Business and Management Functions for Establishing a Strong Presence in Global Markets SEOUL, South Korea, Nov. 15, 2024 /PRNewswire/ -- Neuroph...
2024-11-15 22:00
1647
Acepodia Announces FDA Clearance of Investigational New Drug Application for ACE1831 in IgG4-Related Disease
* IND clearance paves the way for Acepodia to enter the clinic for the first time with its autoimmune program * ACE1831 is an allogeneic gamma delta T cell therapy candidate targeting CD20-expressing cells currently being investigated in non-Hodgkin's lymphoma (NHL) * The planned clinical ...
2024-11-15 20:00
1297
Angel Yeast Turns Automation into Opportunity, Ensuring No Job Losses
YICHANG, China, Nov. 15, 2024 /PRNewswire/ -- Angel Yeast has taken a significant step towards modernization and sustainability by automating its packaging line while ensuring no layoffs for its employees. In 2024, with the completion of the intelligent transformation of its packaging workshop, t...
2024-11-15 20:00
1335
Nuvilab: Advancing School Nutrition with AI-Powered Nutrition Coaching, Wins CES 2025 Innovation Award
SEOUL, South Korea, Nov. 15, 2024 /PRNewswire/ -- Nuvilab announced that its innovative AI nutrition coaching solution,NutriTrex, was awarded the CES 2025 Innovation Award in the Digital Health category. This prestigious honor highlights Nuvilab's groundbreaking approach to promoting healthy eati...
2024-11-15 18:31
1410
Ping An Health Launches "Healthy Steps" Initiative to Boost National Health Literacy Through Collaboration
HONG KONG and SHANGHAI, Nov. 14, 2024 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor", "Ping An Health", or "the Company", Stock Code: 1833.HK) launched the "Healthy Steps" National Health Literacy Initiative at the Ping An Finance Center inShanghai. This ...
2024-11-15 11:00
1446
Harbour BioMed Appoints Dr. Raymond Zheng as Chief Business Officer
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Nov. 14, 2024 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunol...
2024-11-15 09:55
1293
Mabwell's Novel Nectin-4 Targeting ADC 9MW2821 Approved for 2 Clinical Trials by CDE of NMPA
SHANGHAI, Nov. 14, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its novel Nectin-4 targeting ADC (R&D code: 9MW2821) has received IND approval for two clinical studies. The first will explore its use in combination wi...
2024-11-14 22:00
1629
Baijiayun Was Awarded the "2024 Future Medical Technology Leader" and Gained Another Industry Recognition
BEIJING, Nov. 14, 2024 /PRNewswire/ -- Baijiayun Group Ltd ("Baijiayun" or the "Company") (NASDAQ: RTC), a one-stop AI video solution provider, today announced it was awarded the "2024 Future Medical Technology Leader". The 2024 Future Medical Technology Conference was grandly held in Beijing. As...
2024-11-14 20:30
1445
I-Mab Reports Third Quarter 2024 Results
* Givastomig data presented at ESMO 2024 and SITC 2024 highlights encouraging monotherapy data * On track to dose first patient in randomized Phase 2 study of uliledlimab in first-line mNSCLC in 1H 2025 * Appointed Dr. Sean Fu as permanent CEO effective November 1, 2024 * Estimated cash ru...
2024-11-14 20:00
1049
Transforming Healthcare with Real-Time AI Image Analytic
Join us to discover how NVIDIA IGX and SDVoE enable seamless ultra-low latency solutions TAIPEI, Nov. 14, 2024 /PRNewswire/ -- Advantech announces enhanced AI detection for endoscopy surgical systems with the integration of its MIC-735M-IO, powered by NVIDIA IGX™, and the VEGA series ultra-low-l...
2024-11-14 18:37
1234
Join the GenScript Biotech Global Forum in London to Navigate the Future of Cell and Gene Therapies.
PISCATAWAY, N.J., Nov. 13, 2024 /PRNewswire/ -- The global cell and gene therapy (CGT) industry is poised for remarkable growth, driven by significant advances in life sciences and robust investments from capital markets. To strengthen this vital sector, GenScript is bringing together leading sc...
2024-11-13 23:51
1043
Week's Top Stories
Most Reposted
PARKROYAL COLLECTION MARINA BAY IS THE FIRST HOTEL IN SINGAPORE TO ATTAIN THREE PRESTIGIOUS SUSTAINABILITY CERTIFICATIONS
[Picked up by 323 media titles]
2024-12-19 13:41
Mayapada Hospitality Holding Open the first voco Hotel in Indonesia.
[Picked up by 309 media titles]
2024-12-20 16:25
Magic Compass Group Sponsors 2024 World Taekwondo Poomsae Championship
[Picked up by 308 media titles]
2024-12-19 17:56
AI and Cyber Security Dominate ASEAN Enterprises' Digital Transformation Priorities
[Picked up by 306 media titles]
2024-12-20 18:11
XTransfer and OCBC Jointly Announce Comprehensive Partnership
[Picked up by 263 media titles]
2024-12-23 17:36
Most Read
AI and Cyber Security Dominate ASEAN Enterprises' Digital Transformation Priorities
2024-12-20 18:11
9425
Magic Compass Group Sponsors 2024 World Taekwondo Poomsae Championship
2024-12-19 17:56
9076
